Literature DB >> 31725156

'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS).

Christian Torp-Pedersen1, Andreas Goette2, Peter Bronnum Nielsen1, Tatjana Potpara3,4, Laurent Fauchier5, Alan John Camm6, Elena Arbelo7,8,9, Giuseppe Boriani10, Flemming Skjoeth11, John Rumsfeld12, Frederick Masoudi13, Yutao Guo14, Boyoung Joung15, Marwan M Refaat16, Young-Hoon Kim17, Christine M Albert18, Jonathan Piccini19, Alvaro Avezum20, Gregory Y H Lip21,22.   

Abstract

The field of observational studies or "real world studies" is in rapid development with many new techniques introduced and increased understanding of traditional methods. For this reason the current paper provides an overview of current methods with focus on new techniques. Some highlights can be emphasized: We provide an overview of sources of data for observational studies. There is an overview of sources of bias and confounding. Next There is an overview of causal inference techniques that are increasingly used. The most commonly used techniques for statistical modelling are reviewed with focus on the important distinction of risk versus prediction. The final section provides examples of common problems with reporting observational data. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arrhythmias; Atrial fibrillation; Database; EHRA position paper; Epidemiological study; European Heart Rhythm Association; Meta-analysis; Methodology; Nationwide cohort; Real-world observational study; Registry

Mesh:

Year:  2020        PMID: 31725156     DOI: 10.1093/europace/euz210

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort.

Authors:  Gregory Y H Lip; Giuseppe Boriani; Vincenzo L Malavasi; Marco Vitolo; Jacopo Colella; Francesca Montagnolo; Marta Mantovani; Marco Proietti; Tatjana S Potpara
Journal:  Intern Emerg Med       Date:  2021-12-02       Impact factor: 5.472

Review 2.  Cardiovascular Research Using the Korean National Health Information Database.

Authors:  Eue Keun Choi
Journal:  Korean Circ J       Date:  2020-05-20       Impact factor: 3.243

3.  Ambulatory ECG monitoring for syncope and collapse in United States, Europe, and Japan: The patients' viewpoint.

Authors:  Meltem Altinsoy; Richard Sutton; Ritsuko Kohno; Scott Sakaguchi; Robin K Mears; David G Benditt
Journal:  J Arrhythm       Date:  2021-05-24

Review 4.  Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.

Authors:  Andreas Goette; Uwe Lendeckel
Journal:  Cells       Date:  2021-09-30       Impact factor: 6.600

5.  Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes.

Authors:  Man Ki Kwok; Catherine Mary Schooling
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

6.  Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study.

Authors:  Sigrun Halvorsen; Jørgen Anton Smith; Fabian Söderdahl; Marcus Thuresson; Oddvar Solli; Maria Ulvestad; Christian Jonasson
Journal:  BMC Prim Care       Date:  2022-08-25

7.  Impact of Integrating Machine Learning in Comparative Effectiveness Research of Oral Anticoagulants in Patients with Atrial Fibrillation.

Authors:  Sola Han; Hae Sun Suh
Journal:  Int J Environ Res Public Health       Date:  2022-10-09       Impact factor: 4.614

8.  Anticoagulant Therapy in Initially Low-Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors.

Authors:  Sun Young Choi; Moo Hyun Kim; Kwang Min Lee; Young-Rak Cho; Jong Sung Park; Seong Woo Kim; Jin Kyung Kim; Matthew Chung; Sung-Cheol Yun; Gregory Y H Lip
Journal:  J Am Heart Assoc       Date:  2020-08-11       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.